Quince Therapeutics, Inc. research brief

CIK 1662774 Copy CIK

Generated Nov. 13, 2026, 6:59 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: South San Francisco California. Reported legal jurisdiction: CALIFORNIA. These do not establish investor residence or where funds were deployed.

• June 11, 2026 · D · 0000912282-26-000811 · Source evidence

  Reported offering amount: 7387671 USD. Reported amount sold: 0 USD.

• June 11, 2026 · D · 0000912282-26-000809 · Source evidence

  Reported offering amount: 186422679 USD. Reported amount sold: 114720542 USD.

• July 1, 2025 · D · 0001662774-25-000035 · Source evidence

  Reported offering amount: 21896618 USD. Reported amount sold: 11488304 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Quince Therapeutics, Inc. research brief,” CIK 1662774, retrieved Nov. 13, 2026, 6:59 p.m.. Cite the specific accessions used. No amounts have been summed.